Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients.

Hinden L, Avner M, Stepensky P, Or R, Almogi-Hazan O. Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. PLoS One. 2019;14(6):e0217572.